相关实验视频
Updated: Jul 2, 2025

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.5K
慢性疹中抗组胺药物的临床反应的风险计算器:开发和内部验证
Jorge Sánchez1, Fabian Jaimes2, Elizabeth García3
1Group of Clinical and Experimental Allergy, "IPS University" Clinic, University of Antioquia, Medellín, Colombia.
PloS one
|February 23, 2024
概括
这项研究开发了一种模型,用于预测慢性自发性疹 (CSU) 患者的抗组胺反应. 早期识别不响应者可以指导及时的替代治疗,以更好地管理CSU.
科学领域:
- 皮肤病学 皮肤病学
- 过敏学 过敏学
- 临床预测建模临床预测建模
背景情况:
- 慢性自发性疹 (CSU) 在临床实践中构成了重大挑战.
- 早期识别不太可能对抗胰岛素药物有反应的患者对于有效的管理至关重要.
- 及时启动替代疗法可以改善患者的治疗结果.
研究的目的:
- 开发和内部验证成年CSU患者抗组胺反应的预测模型.
- 帮助过敏学和皮肤病学中心分层患者进行个性化治疗.
主要方法:
- 一项前性队列研究对790名CSU患者进行了12个月的跟踪.
- 多变量逻辑回归分析包含15个候选变量.
- 使用引导分析 (1000次模拟) 进行内部验证.
- 随着时间的推移,由疹活动评分 (UAS7) 定义的临床反应.
主要成果:
- 一个包括年龄,血管,焦虑/抑郁,疾病持续时间,NSAID不耐受性和基线UAS7在内的预测模型显示出最佳性能 (精度0.675,AUC0.727).
- 内部验证证实了模型的良好的一致性.
- 该模型有效地区分了对抗胰岛素药物的反应者和不反应者.
结论:
- 一个经过验证的预测模型可以确定CSU患者对抗胰岛素药物的反应概率较低.
- 该工具支持CSU管理中的个性化治疗策略.
- 有助于迅速考虑非响应患者的替代治疗方法.
相关概念视频
Allergic Reactions
27.4K
Overview
27.4K
Hazard Ratio
122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
122
Upper Respiratory Drugs: First and Second-Generation Antihistamines
274
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
274
Hypersensitivities
642
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
642
Allergic Drug Reactions
842
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
842
Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K

